Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.
Appendix B: Panel Roster and Financial Disclosures
Last Updated: November 1, 2012; Last Reviewed: November 1, 2012
|Cohn, David||University of Colorado School of Medicine||None||N/A|
||University of California, Los Angeles
|EMD Seronon||Advisory Board|
|Janssen-Cilag||Honoraria, Travel Support|
|Merck||Advisory Board, Research Support|
|Tibotec||Advisory Support, Research Support, Travel Support|
|Dorman, Susan||Johns Hopkins University||Bill and Melinda Gates Foundation||Research Support|
||Veterans Affairs Medical Center; Washington , DC
|Horsburgh, C. Robert||Boston University||Bill and Melinda Gates Foundation||Travel Support|
|Medical Research Council (UK)||Travel Support|
|* Group lead
Note: Members were asked to disclose all relationships from 24 months before the writing panel convened. The period of reporting was from June 1, 2008, through November 1, 2012.
- CDC | 2015 STD Treatment Guidelines
- HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
- AIDSinfo Patient Materials: What is an Opportunistic Infection?
- AIDSource | HIV-Related Conditions
- AETC National HIV Curriculum
- How to Cite These Guidelines
- Adult and Adolescent OI Guidelines Archive